Delivery Order SPE2DR25D2213-SPE2DR26F6DDF
Award Date 12/22/25
Potential Completion Date 12/23/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,930.97 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product for respiratory treatment. The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this competitively awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,247.90 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This competitive, non-set-aside delivery order was executed on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The firm fixed price contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,331.47 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 (60-count inhalers), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This non-competitive delivery order, issued on November 10, 2025, with completion expected by November 12, 2025, represents a firm fixed-price pharmaceutical supply transaction. The award was fulfilled from AmerisourceBergen's place of performance in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,955.63 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,752.46 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on October 30, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of October 31, 2025. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $10,943.18 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination respiratory medication) in a 60-dose configuration. This non-set-aside, competitively awarded contract carries firm fixed pricing and is scheduled for completion by December 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,536.83 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication, on November 18, 2025. This non-set-aside, firm fixed price delivery order is scheduled for completion by November 19, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a standard transactional purchase under the company's broader federal contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,997.57 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease management. The contract, issued on December 16, 2025, with an ultimate completion date of December 17, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $19,941.01 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 200-62.5-25, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a non-competitive, non-set-aside award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,211.94 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of December 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...